0
Epatik

Epatik 30 Comp DRASANVI

15.65 €
Tax included Delivery time is between 3 and 4 business days, within the peninsula.
8436044510441

Contributes to maintaining normal liver function. Epatik tablets are a food supplement that, thanks to its choline content, contributes to maintaining normal liver function. In addition to choline, we have included 10 other ingredients: boldo, artichoke, sarsaparilla, dandelion, burdock, and well-known ingredients such as desmodium and milk thistle.

Last items in stock

Hurry up! Only 1 item(s) left in Stock!

Ingredients:

Bulking agent (microcrystalline cellulose), Boldo dry extract (leaf) (Peumus boldus Molina, boldin 0.5%) 150 mg, Artichoke dry extract (leaf) (Cynara scolymus L., cynarin 2.5%) 150 mg, Dandelion dry extract (aerial parts) (Taraxacum officinale Weber, inulin 2%) 150 mg, Milk thistle dry extract (seed) (Silybum marianum (L.), silymarin 80%) 150 mg, Desmodium dry extract (aerial parts) (Desmodium ascendens (Sw.) DC) 150 mg, Burdock dry extract (root) (Arctium lappa L., inulin 2%) 150 mg, Sarsaparilla dry extract (root) (Smilax aspera L.) 150 mg, Choline (choline bitartrate) 82.5 mg, L-methionine 60 mg, Inositol 60 mg, Bulking agent (Magnesium salt of fatty acid), Vitamin B6 (Pyridoxine hydrochloride) 4 mg, Anti-caking agent (Silicon dioxide)

Directions for use:

Take 2 tablets daily with breakfast and dinner.

Presentation:

Pack of 30 tablets of 816 mg. Total weight: 24.48 g (0.86 oz)

Warnings:

Food supplement based on plants and choline.

Food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle.

Do not exceed the expressly recommended daily dose. Keep out of reach of young children. Store in a cool, dry place. Do not administer to pregnant or breastfeeding women, or children.

Nutritional values:

per daily dose (2 tablets) Ingredient Percentage Amount Vitamin B6 285% 4 mg % NRV (Nutrient Reference Value)

8436044510441
1 Item

Specific References

EAN13
8436044510441

Epatik 30 Comp DRASANVI

15.65 €
Comments (0)